Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine vs Treatment Choice in Older AML Patients
NCT00260832Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2005
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of decitabine in acute myeloid leukemia (AML), sponsored by Eisai Co., Ltd.. Started Nov 2005; status: completed.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00260832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00260832.